Fall 2023 Newsletter – A Season of Innovation and Growth in Topical DevelopmentAugust 22, 2023
Highlighting the latest trends, accomplishments, and innovations in the field of topical development for Zelmic:
Partners and Industry Colleagues:
As the CEO of Zelmic, I am delighted to share our newsletter, highlighting the latest trends, accomplishments, and innovations in the field of topical development. It has been an exciting time for us, and we are proud to be at the forefront of advancing topical pharmaceutical solutions for our clients.
Innovation and Advancements:
At Zelmic, we believe that innovation is the key to success in the evolving dermatological landscape. In spring 2023, our team of scientists and researchers has been working tirelessly to facilitate advancements in field of topical development. From novel formulations, upscaling, analytical development to enhanced in vitro skin penetration testing, and scientific publications. Thereby we have achieved our development goals as an organization and being a trusted end-to-end topical development partner.
Innovation and Advancements:
Collaboration lies at the heart of what we do. Over the past few months, we have forged strategic partnerships with new pharmaceutical companies, CMO and research institutions. These collaborations have strengthened our expertise, expanded our capabilities, and accelerated the pace of development for innovative topical products. We are delighted to share that we have improved the capacity for aseptic topical formulation development through a CMO partner.
Regulatory Compliance and Quality Assurance:
As a CDMO specializing in topical development, ensuring the highest quality and regulatory compliance is our top priority. We are pleased to announce that we have successfully passed rigorous inspections from the Swedish regulatory authority and clients, repeating our commitment to maintaining the highest standards of quality.
Expanding Facilities and Capacity:
As we have presented previously the growing demand for topical products has prompted us to invest significantly in our facilities and expand our development capacity. With the approved state-of-the-art clinical GMP manufacturing unit and cutting-edge analytical equipment, we are better equipped than ever to meet your project requirements and timelines effectively.
Upcoming Events and Conferences:
Zelmic is eager to participate in upcoming events and conferences. Our team will be attending several key industry gatherings where we will share insights, exchange ideas, and engage in meaningful discussions.
We would also like to take this opportunity to express our gratitude to our partners and clients. Your trust and continued collaboration have been instrumental in our success, and we look forward to further strengthening our partnerships in the future.
If you have any inquiries or are interested in exploring potential collaborations, please do not hesitate to reach out to our team. Together, let us seize the opportunities that Fall 2023 brings and continue to drive innovation in topical development.
Thank you for your ongoing support.
David Sagna CEO, ZelmicSee all news